{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:01:59Z","timestamp":1788498119589,"version":"build-2803163510"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11894-025-01021-2","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:01:03Z","timestamp":1761555663000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Update on the Management of Helicobacter pylori Infection in Children and Adolescents"],"prefix":"10.1007","volume":"27","author":[{"given":"Silvana","family":"Bonilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola L","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"issue":"3","key":"1021_CR1","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1136\/gutjnl-2023-331164","volume":"73","author":"M Rugge","year":"2024","unstructured":"Rugge M, Genta RM, Malfertheiner P, Dinis-Ribeiro M, El-Serag H, Graham DY, et al. Re.GA.IN.: the real-world gastritis initiative\u2014updating the updates. Gut. 2024;73(3):407\u201341. https:\/\/doi.org\/10.1136\/gutjnl-2023-331164.","journal-title":"Gut"},{"key":"1021_CR2","unstructured":"IARC. Global burden of gastric cancer attributable to Helicobacter pylori [Internet]. World Health Organ Int Agency Res Cancer. 2025 [cited 2025 August 24]. Available from: https:\/\/www.iarc.who.int\/reference\/global-burden-of-gastric-cancer-attributable-to-helicobacter-pylori\/. Accessed 24 Aug 2025"},{"issue":"4","key":"1021_CR3","doi-asserted-by":"publisher","first-page":"524","DOI":"10.14309\/ajg.0000000000001625","volume":"117","author":"DY Graham","year":"2022","unstructured":"Graham DY, Moss SF. Antimicrobial susceptibility testing for Helicobacter pylori is now widely available: when, how, why. Am J Gastroenterol. 2022;117(4):524\u20138. https:\/\/doi.org\/10.14309\/ajg.0000000000001625.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"1021_CR4","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.14309\/ajg.0000000000003110","volume":"119","author":"WD Chey","year":"2024","unstructured":"Chey WD, Howden CW, Moss SF, Morgan DR, Greer KB, Grover S, et al. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2024;119(9):1730\u201353. https:\/\/doi.org\/10.14309\/ajg.0000000000003110.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"1021_CR5","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1097\/MPG.0000000000004024","volume":"79","author":"M Homan","year":"2024","unstructured":"Homan M, Jones NL, Bontems P, Carroll MW, Czinn SJ, Gold BD, et al. Updated joint ESPGHAN\/NASPGHAN guidelines for management of Helicobacter pylori infection in children and adolescents (2023). J Pediatr Gastroenterol Nutr. 2024;79(3):758\u201385. https:\/\/doi.org\/10.1097\/MPG.0000000000004024.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"1021_CR6","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1053\/j.gastro.2024.06.003","volume":"167","author":"A Patel","year":"2024","unstructured":"Patel A, Laine L, Moayyedi P, Wu J. AGA clinical practice update on integrating potassium-competitive acid blockers into clinical practice: expert review. Gastroenterology. 2024;167(6):1228\u201338. https:\/\/doi.org\/10.1053\/j.gastro.2024.06.003.","journal-title":"Gastroenterology"},{"issue":"6","key":"1021_CR7","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S2468-1253(23)00094-6","volume":"8","author":"Y Li","year":"2023","unstructured":"Li Y, Choi H, Leung K, Jiang F, Graham DY, Leung WK. Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(6):553\u201364. https:\/\/doi.org\/10.1016\/S2468-1253(23)00094-6.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"41","key":"1021_CR8","doi-asserted-by":"publisher","first-page":"100877","DOI":"10.1016\/j.lana.2024.100877","volume":"29","author":"CS Taylor","year":"2024","unstructured":"Taylor CS, McMahon MV, Ward ZJ, Alarid-Escudero F, Camargo MC, Laszkowska M, et al. Birth cohort and age-specific trends in global Helicobacter pylori seroprevalence: a scoping review. Lancet Reg Health Am. 2024;29(41):100877. https:\/\/doi.org\/10.1016\/j.lana.2024.100877.","journal-title":"Lancet Reg Health Am"},{"issue":"3","key":"1021_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S2352-4642(21)00372-5","volume":"6","author":"C Yuan","year":"2022","unstructured":"Yuan C, Adeloye D, Luk TT, Huang L, He Y, Chan PSF, et al. The global prevalence of and factors associated with Helicobacter pylori infection in children: a systematic review and meta-analysis. Lancet Child Adolesc Health. 2022;6(3):185\u201394. https:\/\/doi.org\/10.1016\/S2352-4642(21)00372-5.","journal-title":"Lancet Child Adolesc Health"},{"issue":"1","key":"1021_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12868","volume":"27","author":"JG Huang","year":"2022","unstructured":"Huang JG, Lim SYS, Aw MM, Quak SH. Antibiotic resistance patterns and therapeutic outcomes of pediatric Helicobacter pylori infection in a high-migrant Singaporean cohort. Helicobacter. 2022;27(1):e12868. https:\/\/doi.org\/10.1111\/hel.12868.","journal-title":"Helicobacter"},{"issue":"8","key":"1021_CR11","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s00535-024-02114-x","volume":"59","author":"L Xu","year":"2024","unstructured":"Xu L, Li XT, Ur-Rahman I, Zhang C, Qi YB, Hu RB, et al. Global Helicobacter pylori recurrence, recrudescence, and re-infection status after successful eradication in pediatric patients: a systematic review and meta-analysis. J Gastroenterol. 2024;59(8):668\u201381. https:\/\/doi.org\/10.1007\/s00535-024-02114-x.","journal-title":"J Gastroenterol"},{"issue":"8","key":"1021_CR12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/17474124.2024.2361975","volume":"18","author":"M Sugimoto","year":"2024","unstructured":"Sugimoto M, Murata M, Murakami K, Yamaoka Y, Kawai T. Characteristic endoscopic findings in Helicobacter pylori diagnosis in clinical practice. Expert Rev Gastroenterol Hepatol. 2024;18(8):457\u201372. https:\/\/doi.org\/10.1080\/17474124.2024.2361975.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"4","key":"1021_CR13","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/MPG.0000000000002843","volume":"71","author":"M Kori","year":"2020","unstructured":"Kori M, Le Thi TG, Werkstetter K, Sustmann A, Bontems P, Lopes AI, et al. Helicobacter pylori infection in pediatric patients living in Europe: results of the EuroPedHP registry 2013 to 2016. J Pediatr Gastroenterol Nutr. 2020;71(4):476\u201383. https:\/\/doi.org\/10.1097\/MPG.0000000000002843.","journal-title":"J Pediatr Gastroenterol Nutr."},{"issue":"2","key":"1021_CR14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/MPG.0000000000003152","volume":"73","author":"S Bonilla","year":"2021","unstructured":"Bonilla S, Mitchell PD, Mansuri I. Low adherence to society guidelines for the management of Helicobacter pylori among pediatric gastroenterologists. J Pediatr Gastroenterol Nutr. 2021;73(2):178\u201383. https:\/\/doi.org\/10.1097\/MPG.0000000000003152.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"11","key":"1021_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11111658","volume":"11","author":"TC Nguyen","year":"2023","unstructured":"Nguyen TC, Tang NLC, Le GKN, Nguyen VT, Nguyen KHG, Che TH, et al. Helicobacter pylori infection and peptic ulcer disease in symptomatic children in southern Vietnam: a prospective multicenter study. Healthcare. 2023;11(11):1658. https:\/\/doi.org\/10.3390\/healthcare11111658.","journal-title":"Healthcare"},{"issue":"8","key":"1021_CR16","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1111\/apa.14763","volume":"108","author":"A Chobot","year":"2019","unstructured":"Chobot A, Por\u0119bska J, Krzywicka A, \u017babka A, B\u0105k-Drabik K, Pieni\u0105\u017cek W, et al. No association between Helicobacter pylori infection and gastrointestinal complaints in a large cohort of symptomatic children. Acta Paediatr. 2019;108(8):1535\u201340. https:\/\/doi.org\/10.1111\/apa.14763.","journal-title":"Acta Paediatr"},{"issue":"10263","key":"1021_CR17","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/S0140-6736(20)30469-4","volume":"21","author":"AC Ford","year":"2020","unstructured":"Ford AC, Mahadeva S, Carbone MF, Lacy BE, Talley NJ. Functional dyspepsia. Lancet. 2020;21(10263):1689\u2013702. https:\/\/doi.org\/10.1016\/S0140-6736(20)30469-4.","journal-title":"Lancet"},{"issue":"4","key":"1021_CR18","doi-asserted-by":"publisher","first-page":"709","DOI":"10.14309\/ajg.0000000000003350","volume":"120","author":"DR Morgan","year":"2025","unstructured":"Morgan DR, Corral JE, Li D, Montgomery EA, Riquelme A, Kim JJ, et al. ACG clinical guideline: diagnosis and management of gastric premalignant conditions. Am J Gastroenterol. 2025;120(4):709\u201337. https:\/\/doi.org\/10.14309\/ajg.0000000000003350.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1021_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/hel.70021","volume":"30","author":"MA Abdun","year":"2025","unstructured":"Abdun MA, Xu L, Li XT, Mekky A, Al Hussan M, Abuheit EMI, et al. Global prevalence of Helicobacter pylori infection-associated gastric preneoplastic lesions in pediatric patients: a systematic review and meta-analysis. Helicobacter. 2025;30(1):e70021. https:\/\/doi.org\/10.1111\/hel.70021.","journal-title":"Helicobacter"},{"issue":"1","key":"1021_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17010128","volume":"17","author":"J Drnov\u0161ek","year":"2025","unstructured":"Drnov\u0161ek J, Zidar N, Jeruc J, \u0160mid LM, Vidmar G, \u0160tabuc B, et al. Gastric intestinal metaplasia in children and adolescents is reversible upon reaching adulthood: results from a long-term cohort study. Cancers (Basel). 2025;17(1):128. https:\/\/doi.org\/10.3390\/cancers17010128.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"1021_CR21","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/jpn3.70037","volume":"80","author":"A Hoofien","year":"2025","unstructured":"Hoofien A, Ikher S, Kori M. Pediatric gastric intestinal metaplasia: the association with Helicobacter pylori and other gastrointestinal diseases. J Pediatr Gastroenterol Nutr. 2025;80(6):963\u20136. https:\/\/doi.org\/10.1002\/jpn3.70037.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"1021_CR22","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/MPG.0000000000003862","volume":"77","author":"I Mansuri","year":"2023","unstructured":"Mansuri I, Goldsmith JD, Liu E, Bonilla S. Gastric intestinal metaplasia in children: natural history and clinicopathological correlation. J Pediatr Gastroenterol Nutr. 2023;77(3):332\u20138. https:\/\/doi.org\/10.1097\/MPG.0000000000003862.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"1021_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/hel.13113","volume":"29","author":"P Melnik","year":"2024","unstructured":"Melnik P, Weintraub I, Shamaly H, Cohen S, Greenberg-Kushnir N, Schiby G, et al. Helicobacter pylori-associated extranodal marginal zone lymphoma of mucosa-associated tissue in children: a multicenter case series. Helicobacter. 2024;29(4):e13113. https:\/\/doi.org\/10.1111\/hel.13113.","journal-title":"Helicobacter"},{"issue":"3","key":"1021_CR24","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1053\/j.gastro.2020.06.046","volume":"159","author":"CW Ko","year":"2020","unstructured":"Ko CW, Siddique SM, Patel A, Harris A, Sultan S, Altayar O, et al. AGA clinical practice guidelines on the gastrointestinal evaluation of iron deficiency anemia. Gastroenterology. 2020;159(3):1085\u201394. https:\/\/doi.org\/10.1053\/j.gastro.2020.06.046.","journal-title":"Gastroenterology"},{"issue":"5","key":"1021_CR25","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3390\/microorganisms8050699","volume":"8","author":"T Ikuse","year":"2020","unstructured":"Ikuse T, Toda M, Kashiwagi K, Watanabe K, Nakazawa Y, Nakashima K, et al. Efficacy of Helicobacter pylori eradication therapy on platelet recovery in pediatric immune thrombocytopenic purpura: case series and a systematic review. Microorganisms. 2020;8(5):699. https:\/\/doi.org\/10.3390\/microorganisms8050699.","journal-title":"Microorganisms"},{"issue":"11","key":"1021_CR26","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1111\/ped.14478","volume":"62","author":"S Kato","year":"2020","unstructured":"Kato S, Shimizu T, Toyoda S, Sugimoto M, Ozawa K, Azuma T, et al. The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood. Pediatr Int. 2020;62(11):1315\u201331. https:\/\/doi.org\/10.1111\/ped.14478.","journal-title":"Pediatr Int"},{"issue":"5","key":"1021_CR27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa1909666","volume":"382","author":"IJ Choi","year":"2020","unstructured":"Choi IJ, Kim CG, Lee JY, Kim YI, Kook MC, Park B, et al. Family history of gastric cancer and Helicobacter pylori treatment. N Engl J Med. 2020;382(5):427\u201336. https:\/\/doi.org\/10.1056\/NEJMoa1909666.","journal-title":"N Engl J Med"},{"issue":"1","key":"1021_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5230\/jgc.2023.23.e11","volume":"23","author":"TH Kim","year":"2023","unstructured":"Kim TH, Kim IH, Kang SJ, Choi M, Kim BH, Eom BW, et al. Korean practice guidelines for gastric cancer 2022: an evidence-based, multidisciplinary approach. J Gastric Cancer. 2023;23(1):3\u2013106. https:\/\/doi.org\/10.5230\/jgc.2023.23.e11.","journal-title":"J Gastric Cancer"},{"issue":"12","key":"1021_CR29","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1136\/gutjnl-2023-331732","volume":"73","author":"M Leja","year":"2024","unstructured":"Leja M. Where are we with gastric cancer screening in Europe in 2024? Gut. 2024;73(12):2074\u201382. https:\/\/doi.org\/10.1136\/gutjnl-2023-331732.","journal-title":"Gut"},{"issue":"2","key":"1021_CR30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1053\/j.gastro.2024.10.031","volume":"168","author":"SC Shah","year":"2025","unstructured":"Shah SC, Wang AY, Wallace MB, Hwang JH. AGA clinical practice update on screening and surveillance in individuals at increased risk for gastric cancer in the United States: expert review. Gastroenterology. 2025;168(2):405-16.e1. https:\/\/doi.org\/10.1053\/j.gastro.2024.10.031.","journal-title":"Gastroenterology"},{"issue":"1","key":"1021_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-89981-3","volume":"15","author":"GZ Fan","year":"2025","unstructured":"Fan GZ, Duan BY, Xin FJ, Qu ZH. Assessment of the bidirectional causal association between Helicobacter pylori infection and allergic diseases by Mendelian randomization analysis. Sci Rep. 2025;15(1):5746. https:\/\/doi.org\/10.1038\/s41598-025-89981-3.","journal-title":"Sci Rep"},{"issue":"24","key":"1021_CR32","doi-asserted-by":"publisher","first-page":"10509","DOI":"10.26355\/eurrev_201912_19796","volume":"23","author":"WL Wang","year":"2019","unstructured":"Wang WL, Xu XJ. Correlation between Helicobacter pylori infection and Crohn\u2019s disease: a meta-analysis. Eur Rev Med Pharmacol Sci. 2019;23(24):10509\u201318. https:\/\/doi.org\/10.26355\/eurrev_201912_19796.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"7","key":"1021_CR33","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/apt.70042","volume":"61","author":"I Spinelli","year":"2025","unstructured":"Spinelli I, Porcari S, Esposito C, Fusco W, Ponziani FR, Caruso C, et al. Meta-analysis: inverse association between Helicobacter pylori infection and eosinophilic oesophagitis. Aliment Pharmacol Ther. 2025;61(7):1096\u2013109. https:\/\/doi.org\/10.1111\/apt.70042.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"1021_CR34","doi-asserted-by":"publisher","DOI":"10.1111\/hel.70038","volume":"30","author":"L Guti\u00e9rrez-Ram\u00edrez","year":"2025","unstructured":"Guti\u00e9rrez-Ram\u00edrez L, Garcia-Dionisio SL, Feo-Ortega S, Gonz\u00e1lez-Cervera J, Tejera-Mu\u00f1oz A, Lucendo AJ, et al. The association between Helicobacter pylori infection and eosinophilic esophagitis: systematic review and meta-analysis. Helicobacter. 2025;30(2):e70038. https:\/\/doi.org\/10.1111\/hel.70038.","journal-title":"Helicobacter"},{"key":"1021_CR35","doi-asserted-by":"publisher","unstructured":"Wang H, Qu Y, Lin Y, Liu Z, Lagergren J, Yuan S, et al. Helicobacter pylori infection and eradication in relation to gastroesophageal reflux disease. J Gastroenterol Hepatol. 2025. https:\/\/doi.org\/10.1111\/jgh.16669.","DOI":"10.1111\/jgh.16669"},{"issue":"3","key":"1021_CR36","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1053\/j.gastro.2024.05.041","volume":"167","author":"AK Wiklund","year":"2024","unstructured":"Wiklund AK, Santoni G, Yan J, Radkiewicz C, Xie S, Birgisson H, et al. Risk of esophageal adenocarcinoma after Helicobacter pylori eradication treatment in a population-based multinational cohort study. Gastroenterology. 2024;167(3):485-92.e3. https:\/\/doi.org\/10.1053\/j.gastro.2024.05.041.","journal-title":"Gastroenterology"},{"issue":"2","key":"1021_CR37","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3390\/jcm9020274","volume":"9","author":"AT Dom\u0219a","year":"2020","unstructured":"Dom\u0219a AT, Gheban D, Laz\u0103r C, Copotoiu SM, Chira RI, M\u0103rginean IC, et al. Particular morphological features in the diagnosis of pediatric Helicobacter pylori gastritis: a morphometry-based study. J Clin Med. 2020;9(2):274. https:\/\/doi.org\/10.3390\/jcm9020274.","journal-title":"J Clin Med"},{"issue":"1","key":"1021_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/MPG.0000000000003301","volume":"74","author":"N Kalach","year":"2022","unstructured":"Kalach N, Misak Z, Bontems P, Kori M, Homan M, Cabral J, et al. Systematic review and meta-analysis of histological gastric biopsy aspects according to the updated Sydney system in children. J Pediatr Gastroenterol Nutr. 2022;74(1):13\u20139. https:\/\/doi.org\/10.1097\/MPG.0000000000003301.","journal-title":"J Pediatr Gastroenterol Nutr."},{"issue":"8","key":"1021_CR39","first-page":"469","volume":"20","author":"CB Andrews","year":"2024","unstructured":"Andrews CB, Herzlinger MI, Moss SF. Helicobacter pylori antimicrobial resistance and the role of next-generation sequencing. Gastroenterol Hepatol (N Y). 2024;20(8):469\u201376.","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"5","key":"1021_CR40","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1053\/j.gastro.2021.07.055","volume":"161","author":"KG Hulten","year":"2021","unstructured":"Hulten KG, Genta RM, Kalfus IN, Zhou Y, Zhang H, Graham DY. Comparison of culture with antibiogram to next-generation sequencing using bacterial isolates and formalin-fixed, paraffin-embedded gastric biopsies. Gastroenterology. 2021;161(5):1433-42.e2. https:\/\/doi.org\/10.1053\/j.gastro.2021.07.055.","journal-title":"Gastroenterology"},{"issue":"13","key":"1021_CR41","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1016\/j.cgh.2023.02.026","volume":"21","author":"M Herzlinger","year":"2023","unstructured":"Herzlinger M, Dannheim K, Riaz M, Liu E, Bousvaros A, Bonilla S. Helicobacter pylori antimicrobial resistance in a pediatric population from the New England region of the United States. Clin Gastroenterol Hepatol. 2023;21(13):3458-60.e2. https:\/\/doi.org\/10.1016\/j.cgh.2023.02.026.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"1021_CR42","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/MPG.0000000000000802","volume":"61","author":"N Kalach","year":"2015","unstructured":"Kalach N, Gosset P, Dehecq E, et al. Usefulness of gastric biopsy-based real-time polymerase chain reaction for the diagnosis of Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr. 2015;61(3):307\u201312. https:\/\/doi.org\/10.1097\/MPG.0000000000000802.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"1021_CR43","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1186\/s12876-020-01564-0","volume":"20","author":"T Kakiuchi","year":"2020","unstructured":"Kakiuchi T, Hashiguchi K, Imamura I, et al. Assessment of a novel method to detect clarithromycin-resistant Helicobacter pylori using a stool antigen test reagent. BMC Gastroenterol. 2020;20(1):397. https:\/\/doi.org\/10.1186\/s12876-020-01564-0.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"1021_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12450","volume":"23","author":"G Beer-Davidson","year":"2018","unstructured":"Beer-Davidson G, Hindiyeh M, Muhsen K. Detection of Helicobacter pylori in stool samples of young children using real-time polymerase chain reaction. Helicobacter. 2018;23(1):e12450. https:\/\/doi.org\/10.1111\/hel.12450.","journal-title":"Helicobacter"},{"issue":"6","key":"1021_CR45","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/hel.12307","volume":"21","author":"S George","year":"2016","unstructured":"George S, Mamani N, Lucero Y, et al. Detection of Helicobacter pylori by real-time PCR for 16S rRNA in stools of noninfected healthy children, using ELISA antigen stool test as the gold standard. Helicobacter. 2016;21(6):606\u201312. https:\/\/doi.org\/10.1111\/hel.12307.","journal-title":"Helicobacter"},{"issue":"7","key":"1021_CR46","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1053\/j.gastro.2022.02.027","volume":"162","author":"SF Moss","year":"2022","unstructured":"Moss SF, Dang LP, Chua D, Sobrado J, Zhou Y, Graham DY. Comparable results of Helicobacter pylori antibiotic resistance testing of stools vs gastric biopsies using next-generation sequencing. Gastroenterology. 2022;162(7):2095-7.e2. https:\/\/doi.org\/10.1053\/j.gastro.2022.02.027.","journal-title":"Gastroenterology"},{"issue":"5","key":"1021_CR47","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/MPG.0000000000003801","volume":"77","author":"S Bonilla","year":"2023","unstructured":"Bonilla S, Goldsmith J, Mitchell P, Bousvaros A. Helicobacter pylori antimicrobial resistance using next-generation sequencing in stool samples in a pediatric population. J Pediatr Gastroenterol Nutr. 2023;77(5):623\u20137. https:\/\/doi.org\/10.1097\/MPG.0000000000003801.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"23","key":"1021_CR48","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","volume":"3","author":"C Neunert","year":"2019","unstructured":"Neunert C, Terrell DR, Arnold DM, et al. American society of hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829\u201366. https:\/\/doi.org\/10.1182\/bloodadvances.2019000966.","journal-title":"Blood Adv"},{"key":"1021_CR49","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6090878","volume":"2018","author":"BJ Kim","year":"2018","unstructured":"Kim BJ, Kim HS, Jang HJ, Kim JH. Helicobacter pylori eradication in idiopathic thrombocytopenic purpura: a meta-analysis of randomized trials. Gastroenterol Res Pract. 2018;2018:6090878. https:\/\/doi.org\/10.1155\/2018\/6090878.","journal-title":"Gastroenterol Res Pract"},{"issue":"2","key":"1021_CR50","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1053\/j.gastro.2025.04.054","volume":"169","author":"AK Wiklund","year":"2025","unstructured":"Wiklund AK, Santoni G, Yan J, Radkiewicz C, Xie S, Birgisson H, et al. Risk of gastric adenocarcinoma after eradication of Helicobacter pylori. Gastroenterology. 2025;169(2):244-50.e1. https:\/\/doi.org\/10.1053\/j.gastro.2025.04.054.","journal-title":"Gastroenterology"},{"issue":"8","key":"1021_CR51","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.14309\/ajg.0000000000001847","volume":"117","author":"JJC Ho","year":"2022","unstructured":"Ho JJC, Navarro M, Sawyer K, Elfanagely Y, Moss SF. Helicobacter pylori antibiotic resistance in the United States between 2011 and 2021: a systematic review and meta-analysis. Am J Gastroenterol. 2022;117(8):1221\u201330. https:\/\/doi.org\/10.14309\/ajg.0000000000001847.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1021_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03816-y","volume":"22","author":"A Salahi-Niri","year":"2024","unstructured":"Salahi-Niri A, Nabavi-Rad A, Monaghan TM, Rokkas T, Doulberis M, Sadeghi A, et al. Global prevalence of Helicobacter pylori antibiotic resistance among children in the world health organization regions between 2000 and 2023: a systematic review and meta-analysis. BMC Med. 2024;22(1):598. https:\/\/doi.org\/10.1186\/s12916-024-03816-y.","journal-title":"BMC Med"},{"issue":"4","key":"1021_CR53","doi-asserted-by":"publisher","first-page":"701","DOI":"10.17219\/acem\/38554","volume":"25","author":"B Iwa\u0144czak","year":"2016","unstructured":"Iwa\u0144czak B, Borys-Iwanicka A, Biernat M, Go\u015bciniak G. Assessment of sequential and standard triple therapy in treatment of Helicobacter pylori infection in children dependent on bacteria sensitivity to antibiotics. Adv Clin Exp Med. 2016;25(4):701\u20138. https:\/\/doi.org\/10.17219\/acem\/38554.","journal-title":"Adv Clin Exp Med"},{"issue":"6","key":"1021_CR54","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1053\/j.gastro.2021.02.014","volume":"160","author":"EA Argueta","year":"2021","unstructured":"Argueta EA, Alsamman MA, Moss SF, D\u2019Agata EMC. Impact of antimicrobial resistance rates on eradication of Helicobacter pylori in a US population. Gastroenterology. 2021;160(6):2181-2183.e1. https:\/\/doi.org\/10.1053\/j.gastro.2021.02.014.","journal-title":"Gastroenterology"},{"issue":"2","key":"1021_CR55","doi-asserted-by":"publisher","first-page":"112","DOI":"10.5455\/medarh.2021.75.112-115","volume":"75","author":"H Thieu","year":"2021","unstructured":"Thieu H, Duc N, Nghi B, et al. Antimicrobial resistance and the successful eradication of Helicobacter pylori-induced gastroduodenal ulcers in Vietnamese children. Med Arch. 2021;75(2):112\u20135. https:\/\/doi.org\/10.5455\/medarh.2021.75.112-115.","journal-title":"Med Arch"},{"issue":"3","key":"1021_CR56","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1097\/MPG.0000000000001257","volume":"64","author":"CA Serrano","year":"2017","unstructured":"Serrano CA, Leon MA, Palma C, Vera M, Hernandez C, Harris PR. Helicobacter pylori-clarithromycin resistance in symptomatic pediatric patients in a high prevalence country. J Pediatr Gastroenterol Nutr. 2017;64(3):e56-60. https:\/\/doi.org\/10.1097\/MPG.0000000000001257.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1021_CR57","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8130596","volume":"2017","author":"GH Ustundag","year":"2017","unstructured":"Ustundag GH, Altuntas H, Soysal YD, Kokturk F. The effects of synbiotic \u201cBifidobacterium lactis B94 plus Inulin\u201d addition on standard triple therapy of Helicobacter pylori eradication in children. Can J Gastroenterol Hepatol. 2017;2017:8130596. https:\/\/doi.org\/10.1155\/2017\/8130596.","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"56","key":"1021_CR58","doi-asserted-by":"publisher","first-page":"96409","DOI":"10.18632\/oncotarget.21633","volume":"8","author":"J Wen","year":"2017","unstructured":"Wen J, Peng P, Chen P, Zeng L, Pan Q, Wei W, et al. Probiotics in 14-day triple therapy for Asian pediatric patients with Helicobacter pylori infection: a network meta-analysis. Oncotarget. 2017;8(56):96409\u201318. https:\/\/doi.org\/10.18632\/oncotarget.21633.","journal-title":"Oncotarget"},{"issue":"1","key":"1021_CR59","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12764","volume":"26","author":"E Miyata","year":"2021","unstructured":"Miyata E, Kudo T, Ikuse T, Tokita K, Arai N, Oka I, et al. Eradication therapy for Helicobacter pylori infection based on the antimicrobial susceptibility test in children: a single-center study over 12 years. Helicobacter. 2021;26(1):e12764. https:\/\/doi.org\/10.1111\/hel.12764.","journal-title":"Helicobacter"},{"key":"1021_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/jpn3.70191","author":"C Chan","year":"2025","unstructured":"Chan C, Bousvaros A, Goldsmith JD, Liu E, Bonilla S. Antimicrobial susceptibility-guided treatment is superior to empiric therapy for Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr. 2025. https:\/\/doi.org\/10.1002\/jpn3.70191.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"1021_CR61","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cgh.2019.02.042","volume":"18","author":"AG McNicholl","year":"2020","unstructured":"McNicholl AG, Bordin DS, Lucendo A, Fadeenko G, Fernandez MC, Voynovan I, et al. Combination of bismuth and standard triple therapy eradicates Helicobacter pylori infection in more than 90% of patients. Clin Gastroenterol Hepatol. 2020;18(1):89\u201398. https:\/\/doi.org\/10.1016\/j.cgh.2019.02.042.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"1021_CR62","doi-asserted-by":"publisher","first-page":"e12679","DOI":"10.1111\/hel.12679","volume":"25","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Ye Z, Wang Y, Zhang Z, Li Y, Chen X, et al. Comparison of four different regimens against Helicobacter pylori as a first-line treatment: a prospective, cross-sectional, comparative, open trial in Chinese children. Helicobacter. 2020;25(2):e12679. https:\/\/doi.org\/10.1111\/hel.12679.","journal-title":"Helicobacter"},{"issue":"4","key":"1021_CR63","doi-asserted-by":"publisher","first-page":"e12825","DOI":"10.1111\/hel.12825","volume":"26","author":"K Kotilea","year":"2021","unstructured":"Kotilea K, Cadranel S, Salame A, Romba M, Smets F, Kalach N, et al. Efficacy and safety of bismuth-based quadruple therapy for Helicobacter pylori eradication in children. Helicobacter. 2021;26(4):e12825. https:\/\/doi.org\/10.1111\/hel.12825.","journal-title":"Helicobacter"},{"issue":"6","key":"1021_CR64","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3390\/children10061121","volume":"10","author":"LTT Le","year":"2022","unstructured":"Le LTT, Nguyen TA, Nguyen NA, Tran TH, Vo TT, Pham HT, et al. Helicobacter pylori eradication efficacy of therapy based on the antimicrobial susceptibility in children with gastritis and peptic ulcer in Mekong Delta, Vietnam. Children (Basel). 2022;10(6):1121. https:\/\/doi.org\/10.3390\/children10061121.","journal-title":"Children (Basel)"},{"issue":"1","key":"1021_CR65","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1186\/s12887-024-05020-6","volume":"24","author":"R Miao","year":"2024","unstructured":"Miao R, Chen J, Gao S, Wang L, Zhou W, Wan C, et al. A randomised controlled clinical study of standard triple therapy, bismuth-based quadruple therapy and sequential therapy for Helicobacter pylori infection in children. BMC Pediatr. 2024;24(1):543. https:\/\/doi.org\/10.1186\/s12887-024-05020-6.","journal-title":"BMC Pediatr"},{"issue":"6","key":"1021_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197096","volume":"13","author":"H Salmanroghani","year":"2018","unstructured":"Salmanroghani H, Mirvakili M, Baghbanian M, Salmanroghani R, Sanati G, Yazdian P. Efficacy and tolerability of two quadruple regimens: bismuth, omeprazole, metronidazole with amoxicillin or tetracycline as first-line treatment for eradication of Helicobacter pylori in patients with duodenal ulcer: a randomized clinical trial. PLoS One. 2018;13(6):e0197096. https:\/\/doi.org\/10.1371\/journal.pone.0197096.","journal-title":"PLoS One"},{"issue":"6","key":"1021_CR67","doi-asserted-by":"publisher","DOI":"10.1111\/hel.70006","volume":"29","author":"V Mishra","year":"2024","unstructured":"Mishra V, Dash D, Panda AK, Pathak SK. Efficacy of Lactobacillus spp. supplementation in Helicobacter pylori eradication: a systematic meta-analysis of randomized controlled trials with trial sequential analysis. Helicobacter. 2024;29(6):e70006. https:\/\/doi.org\/10.1111\/hel.70006.","journal-title":"Helicobacter"},{"issue":"2","key":"1021_CR68","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1053\/j.gastro.2025.04.012","volume":"169","author":"AC Ford","year":"2025","unstructured":"Ford AC, Yuan Y, Xiao S, Ma JL, Song M, Wang Q, et al. Eradication therapy to prevent gastric cancer in Helicobacter pylori-positive individuals: systematic review and meta-analysis of randomized controlled trials and observational studies. Gastroenterology. 2025;169(2):261\u201374. https:\/\/doi.org\/10.1053\/j.gastro.2025.04.012.","journal-title":"Gastroenterology"},{"issue":"5","key":"1021_CR69","doi-asserted-by":"publisher","DOI":"10.1111\/hel.13134","volume":"29","author":"TG Le Thi","year":"2024","unstructured":"Le Thi TG, Werkstetter K, Kotilea K, et al. Factors associated with decision to treat or not to treat Helicobacter pylori infection in children: data from the EuroPedHp registry. Helicobacter. 2024;29(5):e13134. https:\/\/doi.org\/10.1111\/hel.13134.","journal-title":"Helicobacter"},{"issue":"6","key":"1021_CR70","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1053\/j.gastro.2021.01.218","volume":"160","author":"SC Shah","year":"2021","unstructured":"Shah SC, Iyer PG, Moss SF. AGA clinical practice update on the management of refractory Helicobacter pylori infection: expert review. Gastroenterology. 2021;160(6):1831\u201341. https:\/\/doi.org\/10.1053\/j.gastro.2021.01.218.","journal-title":"Gastroenterology"},{"issue":"3","key":"1021_CR71","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1053\/j.gastro.2022.06.076","volume":"163","author":"CA Fallone","year":"2022","unstructured":"Fallone CA. The current role of vonoprazan in Helicobacter pylori treatment. Gastroenterology. 2022;163(3):572\u20134. https:\/\/doi.org\/10.1053\/j.gastro.2022.06.076.","journal-title":"Gastroenterology"},{"issue":"12","key":"1021_CR72","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.3390\/jcm11123544","volume":"11","author":"L Fern\u00e1ndez-Salazar","year":"2022","unstructured":"Fern\u00e1ndez-Salazar L, Campillo A, Rodrigo L, Puig I, Castro-Fern\u00e1ndez M, Bujanda L, et al. Effectiveness and safety of high-dose dual therapy: results of the European registry on the management of Helicobacter pylori infection (Hp-EuReg). J Clin Med. 2022;11(12):3544. https:\/\/doi.org\/10.3390\/jcm11123544.","journal-title":"J Clin Med"},{"issue":"3","key":"1021_CR73","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1053\/j.gastro.2022.05.055","volume":"163","author":"WD Chey","year":"2022","unstructured":"Chey WD, M\u00e9graud F, Laine L, L\u00f3pez LJ, Hunt BJ, Howden CW. Vonoprazan triple and dual therapy for Helicobacter pylori infection in the United States and Europe: randomized clinical trial. Gastroenterology. 2022;163(3):608\u201319. https:\/\/doi.org\/10.1053\/j.gastro.2022.05.055.","journal-title":"Gastroenterology"},{"key":"1021_CR74","unstructured":"Takeda Pharmaceuticals. VOQUEZNA\u00ae (vonoprazan) [Internet]. U.S. prescribing information and healthcare professional portal. Available from: https:\/\/voqueznapro.com\/portal. Accessed 15 Aug 2025."},{"issue":"9","key":"1021_CR75","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1136\/gutjnl-2022-327745","volume":"71","author":"P Malfertheiner","year":"2022","unstructured":"Malfertheiner P, Megraud F, Rokkas T, Gisbert JP, Liou JM, Schulz C, et al. Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report. Gut. 2022;71(9):1724\u201362. https:\/\/doi.org\/10.1136\/gutjnl-2022-327745.","journal-title":"Gut"},{"issue":"3","key":"1021_CR76","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s00535-022-01942-z","volume":"58","author":"T Kakiuchi","year":"2023","unstructured":"Kakiuchi T, Matsuo M, Endo H, Matsubara T, Eguchi H, Kagawa T, et al. Efficacy and safety of vonoprazan-based regimen for Helicobacter pylori eradication therapy in Japanese adolescents: a prospective multicenter study. J Gastroenterol. 2023;58(3):196\u2013204. https:\/\/doi.org\/10.1007\/s00535-022-01942-z.","journal-title":"J Gastroenterol"},{"issue":"6","key":"1021_CR77","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s00535-017-1406-2","volume":"53","author":"C Kusano","year":"2018","unstructured":"Kusano C, Gotoda T, Suzuki S, Ikehara H, Moriyama M. Safety of first-line triple therapy with a potassium-competitive acid blocker for Helicobacter pylori eradication in children. J Gastroenterol. 2018;53(6):718\u201324. https:\/\/doi.org\/10.1007\/s00535-017-1406-2.","journal-title":"J Gastroenterol"},{"issue":"8","key":"1021_CR78","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00535-019-01559-9","volume":"54","author":"T Kakiuchi","year":"2019","unstructured":"Kakiuchi T, Matsuo M, Endo H, Urita Y, Aihara M, Nagahara A, et al. A Helicobacter pylori screening and treatment program to eliminate gastric cancer among junior high school students in saga prefecture: a preliminary report. J Gastroenterol. 2019;54(8):699\u2013707. https:\/\/doi.org\/10.1007\/s00535-019-01559-9.","journal-title":"J Gastroenterol"},{"issue":"4","key":"1021_CR79","doi-asserted-by":"publisher","first-page":"e12696","DOI":"10.1111\/hel.12696","volume":"25","author":"E Kaji","year":"2020","unstructured":"Kaji E, Yoden A, Otani M, Kato M, Aoyama N, Yoshida T, et al. Helicobacter pylori test-and-treat strategy for second-year junior high school students aimed at the prevention of gastric cancer in Takatsuki City. Helicobacter. 2020;25(4):e12696. https:\/\/doi.org\/10.1111\/hel.12696.","journal-title":"Helicobacter"},{"issue":"10","key":"1021_CR80","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s00535-020-01709-4","volume":"55","author":"T Gotoda","year":"2020","unstructured":"Gotoda T, Kusano C, Suzuki S, Horii T, Ichijima R, Ikehara H. Clinical impact of vonoprazan-based dual therapy with amoxicillin for Helicobacter pylori infection in a treatment-na\u00efve cohort of junior high school students in Japan. J Gastroenterol. 2020;55(10):969\u201376. https:\/\/doi.org\/10.1007\/s00535-020-01709-4.","journal-title":"J Gastroenterol"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-025-01021-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11894-025-01021-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-025-01021-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:03:28Z","timestamp":1772579008000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11894-025-01021-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1021"],"URL":"https:\/\/doi.org\/10.1007\/s11894-025-01021-2","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"4 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}